Regional Grey Matter Loss and Brain Disconnection Across Alzheimer Disease Evolution

E-ISSN： 1875-533x|18|16|2452-2458

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.18, Iss.16, 2011-06, pp. : 2452-2458

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Correlations between homocysteine and grey matter volume in patients with Alzheimer's disease

Psychogeriatrics, Vol. 15, Iss. 2, 2015-06 ,pp. : 116-122

John Wiley & Sons Inc

Access to resources Recommend Favorite

Targeted Drug Delivery Across the Blood Brain Barrier in Alzheimer's Disease

Current Pharmaceutical Design, Vol. 19, Iss. 37, 2013-11 ,pp. : 6635-6646

Bentham Science Publishers

Access to resources Recommend Favorite

Transport of Cryptotanshinone, a Major Active Triterpenoid in Salvia Miltiorrhiza Bunge Widely Used in the Treatment of Stroke and Alzheimer's Disease, Across the Blood-Brain Barrier

Current Drug Metabolism, Vol. 8, Iss. 4, 2007-05 ,pp. : 365-377

Bentham Science Publishers

Access to resources Recommend Favorite

Neurogenesis in the Adult Brain: Implications for Alzheimer's Disease

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 6, Iss. 5, 2007-10 ,pp. : 303-310

Bentham Science Publishers

Access to resources Recommend Favorite

Brain-targeted drug delivery for Alzheimer's disease

Inpharma, Vol. 1, Iss. 1352, 2002-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite